TELA Bio Inc (NAS:TELA)
$ 3.03 0 (0%) Market Cap: 119.35 Mil Enterprise Value: 143.57 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

TELA Bio Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 04:15PM GMT
Release Date Price: $11.17 (+3.43%)
Alexander Kramer

Hello, everyone, and welcome to the Thursday morning session of the 41st Annual JPMorgan Healthcare Conference. My name is Alex Kramer and I'm an associate in the healthcare investment banking group here at JPMorgan. It is my pleasure to introduce our next presenting company, TELA Bio. I'll now turn it over to our presenter, CEO, Tony Koblish.

Antony Koblish
TELA Bio, Inc. - Co-founder, President, CEO & Director

Thank you, Alex. Thank you to JPMorgan as well for the invitation and the opportunity, and thank you for everybody listening both present and out there. First, I'll acknowledge a forward-looking statement. And next, we'll get into the company. So TELA Bio is a soft tissue company that's focused on the preservation and restoration of tissues in the operating room in the surgical suite. We work with general surgeons, plastic reconstructive surgeons, colorectal surgeons and trauma surgeons. We have an advanced portfolio of tissue reinforced matrices.

We're the only company on the market that has intellectual property and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot